Erick Gamelin, based in Berkeley, CA, US, is currently a Chief Medical Officer at Acrivon Therapeutics, bringing experience from previous roles at innoHealth Group, Arrowhead Pharmaceuticals, Step Pharma and Dynavax Technologies. Erick Gamelin holds a 2019 - 2019 Certificate in CRISPR-Cas @ UC Berkeley Extension. With a robust skill set that includes Oncology, Clinical Trials, Cancer, Immunology, Clinical Research and more, Erick Gamelin contributes valuable insights to the industry. Erick Gamelin has 1 email and 1 mobile phone number on RocketReach.